To investigate role of CIP2A on breast cancer cell growth, we performed CIP2A gene silencing experiment and found that CIP2A levels were indeed downregulated with two different siRNA sequences (siR1 and siR2), leading to complete and partial knocking down results, respectively (Fig. 1a, b). The gene discussed is CIP2A; the disease is breast cancer.